J. Gao (Stockholm, Sweden), J. Lopez-Campos Bodineau (Sevilla, Spain)
Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients
J. Wedzicha (London, United Kingdom), S. Siddiqui (Leicester, United Kingdom), P. Calverley (Liverpool, United Kingdom), A. De La Hoz (Ingelheim am Rhein, Germany), F. Voß (Ingelheim am Rhein, Germany), H. Magnussen (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), D. Singh (Manchester, United Kingdom)
|     |
Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms
D. Álvarez (Valladolid, Spain), A. Cerezo-Hernández (Valladolid, Spain), A. Crespo (Zamora, Spain), F. Moreno (Valladolid, Spain), G. Gutiérrez-Tobal (Valladolid, Spain), R. Hornero (Valladolid, Spain), T. Ruiz (Valladolid, Spain), F. Del Campo (Valladolid, Spain)
| |
Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD
H. Hoch (Aurora, United States of America), R. Gondalia (San Francisco, United States of America), W. Anderson (Aurora, United States of America), M. Barrett (San Francisco, United States of America), S. Szefler (Aurora, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America)
| |
The effect of tiotropium/olodaterol versus tiotropium on COPD exacerbation rates in patients with/without frequent exacerbation history
J. Wedzicha (London, United Kingdom), R. Buhl (Mainz, Germany), A. De La Hoz (Ingelheim am Rhein, Germany), F. Voß (Ingelheim am Rhein, Germany), P. Calverley (Liverpool, United Kingdom)
| |
Assessment of quality of life of bronchiectasis patients associated with asthma and COPD.
P. Vijay Kumar (Pune, India), R. Dhar (Kolkata, India), D. Talwar (Delhi, India), R. Swarnakar (Nagpur, India), A. Shah (Gujarat, India), V. Singh (Jaipur, India), B. Archana (Bengaluru, India), K. Venugopal (Kerala, India), G. Nair (Mumbai, India), S. Sharma (Kolkata, India), D. Prajapat (Delhi, India), S. Batra (Nagpur, India), P. Shah (Gujarat, India), S. Singh ( Jaipur, India), S. Patel (Mumbai, India), S. Madas (Pune, India), S. Limaye (Pune, India), S. Pawar (Pune, India), S. Salvi (Pune, India), J. Chalmers ( Dundee, United Kingdom)
| |
Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR).
F. Schleich (Liege, Belgium), G. Brusselle (Ghent, Belgium), S. Hanon (Bruxelles, Belgium), O. Vandenplas (Yvoir, Belgium), L. Dupont (Leuven, Belgium), R. Peche (Charleroi, Belgium), A. Michils (Bruxelles, Belgium), C. Pilette (Bruxelles, Belgium), O. Michel (Bruxelles, Belgium), S. Graff (Liege, Belgium), H. Nekoee (Liege, Belgium), A. Donneau (Liege, Belgium), J. Halloy (Baudur, Belgium), V. Dufresne (Gosselies, Belgium), J. Noel (Ottignies, Belgium), L. Vandezande (Bouge, Belgium), G. Joos (Ghent, Belgium), R. Louis (Liege, Belgium)
| |
Characteristics and treatment regimens across ERS SHARP severe asthma registries
J. van Bragt (Amsterdam, Netherlands), I. Adcock (London, United Kingdom), G. Anderson (Melbourne, Australia), E. Bel (Amsterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands), J. Busby (Belfast, United Kingdom), G. Canonica (Milan, Italy), H. Cao (East Hanover, NJ, United States of America), K. Chung (London, United Kingdom), Z. Csoma (Budapest, Hungary), D. Davies (Southampton, United Kingdom), B. Dahlen (Huddinge, Sweden), R. Djukanovic (Southampton, United Kingdom), C. Genton (Lausanne, Switzerland), T. Gibson-Latimer (Sheffield, United Kingdom), D. Hamerlijnck (Sheffield, United Kingdom), L. Heaney (Belfast, United Kingdom), E. Heuvelin (Lausanne, Switzerland), I. Horvath (Budapest, Hungary), S. Korn (Mainz, Germany), M. Kots (Parma, Italy), P. Kuna (Lodz, Poland), N. Kwon (Brentford, United Kingdom), R. Louis (Liege, Belgium), R. Naddaf (Amsterdam, Netherlands), V. Plaza (Barcelona, Spain), D. Ramos Barbon (Barcelona, Spain), L. Richards (Amsterdam, Netherlands), S. Skrgat (Golnik, Slovenia), E. Weersink (Amsterdam, Netherlands), V. Yasinska (Huddinge, Sweden), S. Wagers (Maasmechelen, Belgium), A. Maitland-Van Der Zee (Amsterdam, Netherlands)
| |